ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Top Brokers

More Brokers

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
FTSE 100
8,433.76
0.63%
Dow Jones
39,512.84
0.32%
Gold vs US Dollar
2,360.48
0.00%
Brent Oil
82.585
0.00%
Bitcoin
60,786.75
-0.01%
Pepperstone
Advertisement
Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NYSE
  6. Global Cord Blood Corporation (CO)

  7. Global Cord Blood Corporation (CO) News

Global Cord Blood (CO)

Global Cord Blood Corporation
Date:
Sort by:
 Showing the most relevant articles for your search:NYSE:CO
DateTimeSourceHeadlineSymbolCompany
25/04/202421:02Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NYSE:COGlobal Cord Blood Corporation
17/04/202414:03Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NYSE:COGlobal Cord Blood Corporation
19/03/202420:07Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NYSE:COGlobal Cord Blood Corporation
11/03/202420:01Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NYSE:COGlobal Cord Blood Corporation
05/09/202317:18Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NYSE:COGlobal Cord Blood Corporation
22/06/202314:11Edgar (US Regulatory)Notification Filed by National Security Exchange to Report the Removal From Listing and Registration of Matured, Redeemed or Retired Securities Initial Filing Amendments (25-nse)NYSE:COGlobal Cord Blood Corporation
02/06/202319:39Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NYSE:COGlobal Cord Blood Corporation
13/04/202320:14PR Newswire (US)GLOBAL CORD BLOOD CORPORATION ANNOUNCES FAILURE TO FILE INTERIM FINANCIALSNYSE:COGlobal Cord Blood Corporation
13/04/202320:08PR Newswire (US)GLOBAL CORD BLOOD CORPORATION ANNOUNCES FAILURE TO FILE INTERIM FINANCIALSNYSE:COGlobal Cord Blood Corporation
10/04/202321:17Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NYSE:COGlobal Cord Blood Corporation
03/03/202321:20Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NYSE:COGlobal Cord Blood Corporation
03/02/202319:39Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NYSE:COGlobal Cord Blood Corporation
03/02/202313:01Edgar (US Regulatory)Statement of Ownership (sc 13g)NYSE:COGlobal Cord Blood Corporation
02/12/202221:07Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NYSE:COGlobal Cord Blood Corporation
31/10/202220:03Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NYSE:COGlobal Cord Blood Corporation
21/10/202222:15Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NYSE:COGlobal Cord Blood Corporation
26/09/202221:07Business WireGlobal Cord Blood Corporation Announces Appointment of Joint Provisional Liquidators by The Grand Court Of The Cayman IslandsNYSE:COGlobal Cord Blood Corporation
23/09/202219:07TipRanksGlobal Cord Blood trading halted by NYSE for ‘regulatory concern’NYSE:COGlobal Cord Blood Corporation
23/09/202218:52Business WireThe Grand Court of the Cayman Islands Granted Blue Ocean’s Application to Appoint Joint Provisional Liquidators for Global Cord Blood CorporationNYSE:COGlobal Cord Blood Corporation
24/08/202214:02Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NYSE:COGlobal Cord Blood Corporation
16/08/202221:26Edgar (US Regulatory)Annual and Transition Report (foreign Private Issuer) (20-f)NYSE:COGlobal Cord Blood Corporation
16/08/202221:16PR Newswire (US)Global Cord Blood Corporation Files Annual Report on Form 20-FNYSE:COGlobal Cord Blood Corporation
02/08/202213:01Edgar (US Regulatory)Notification That Form 20-f Will Be Submitted Late (nt 20-f)NYSE:COGlobal Cord Blood Corporation
06/07/202221:22Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NYSE:COGlobal Cord Blood Corporation
06/07/202221:16PR Newswire (US)Global Cord Blood Corporation Obtained Injunction Order Against Blue Ocean in respect of Purported EGMNYSE:COGlobal Cord Blood Corporation
05/07/202221:16PR Newswire (US)Global Cord Blood Corporation Reports Financial Results for the Fourth Quarter and Full Year of Fiscal 2022NYSE:COGlobal Cord Blood Corporation
27/06/202213:02Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NYSE:COGlobal Cord Blood Corporation
22/06/202221:01Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NYSE:COGlobal Cord Blood Corporation
17/06/202217:49Dow Jones NewsGlobal Cord Blood Shares Rise 15% After Merger Target Gets FDA Clearance for INDNYSE:COGlobal Cord Blood Corporation
16/06/202221:20PR Newswire (US)Global Cord Blood Corporation Announced Cellenkos Receives FDA Clearance of IND Application for CK0804 as Add on Therapy to Ruxolitinib for the Treatment of MyelofibrosisNYSE:COGlobal Cord Blood Corporation
 Showing the most relevant articles for your search:NYSE:CO

Your Recent History

LSE
PET
Petrel Resources
LSE
VAST
Vast Resources
LSE
TERN
Tern
LSE
SYME
Supply@me Capital
LSE
SCE
Surface Transforms
LSE
SCLP
Scancell
LSE
GKP
Gulf Keystone Petroleum
LSE
AGL
Angle
LSE
POS
Plexus
LSE
BT.A
Bt
LSE
EEE
Empire Metals
LSE
PANR
Pantheon Resources
LSE
OXB
Oxford Biomedica
LSE
ITV
Itv
LSE
GOLD
LSE
SRSP
Sirius Petroleum
Delayed Upgrade Clock
    ADVFN Logo

    United Kingdom
    Company
    Business
    Popular
    Get The App

    Support: +44 (0) 203 8794 460 | support@advfn.com

    By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

    © 2024 ADVFN PLC - All Rights Reserved